Identification of the cellular origin and "stemness" phenotype of Malignant Rhabdoid Tumors (MRT) may represent a new therapeutic approach in paediatric oncology

被引：1
|
作者：
Ramli, Ras A.
Finetti, Martina A.
Selby, Matthew P.
Grabovska, Yura
Crosier, Stephen
Smith, Amanda J.
Clifford, Steven C.
Williamson, Daniel
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4875
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4875
引用
收藏
页数：2
相关论文
共 3 条
  • [1] AN ANALYSIS OF PUTATIVE CELLS OF ORIGIN FOR MALIGNANT RHABDOID TUMOURS (MRT): A FRONTIER FOR DEVELOPMENT OF MRT CANCER MODELLING AND IDENTIFICATION OF POTENTIAL THERAPEUTIC TARGETS
    Ramli, Ras
    Finetti, Martina
    Selby, Matthew
    Grabovska, Yura
    Crosier, Stepehn
    Bailey, Simon
    Clifford, Steven
    Williamson, Daniel
    NEURO-ONCOLOGY, 2018, 20 : 33 - 33
  • [2] Using CRISPR/Cas9 to explore the human kinome: A tool to identify new potential therapeutic targets for malignant rhabdoid tumors (MRT).
    Sredni, Simone Treiger
    Veliceasa, Donna
    Patel, Kashyap
    de Andrade, Alexandre
    Yang, Jian-Ping
    Whittaker, Ross
    Sobel, Elaine
    Behn, Maya
    Hollender, Meredith
    Piper, David R.
    Tomita, Tadanori
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
    Moreno, Natalia
    Holsten, Till
    Mertins, Julius
    Zhogbi, Annabelle
    Johann, Pascal
    Kool, Marcel
    Meisterernst, Michael
    Kerl, Kornelius
    ONCOTARGET, 2017, 8 (49) : 84986 - 84995
1